These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2539673)

  • 1. Comparison of dithiothreitol (DTT) treatment and absorption using autologous EBV-transformed lymphoblastoid cell lines for the depletion of autoreactive antibodies.
    Nicholls C; Russ GR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):774-6. PubMed ID: 2539673
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation of highly sensitized patients based on crossmatches using DTT-treated sera.
    Alarif L; Snyder T; Light JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):742-4. PubMed ID: 2650251
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiidiotypic antibodies: production in vitro by EBV-transformed lymphoblastoid cell lines and immunochemical characterization of idiotypic receptors on T-cells.
    Singal DP; Joseph S; Frame B; Ludwin D; Mervart H; Blajchman MA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):333-5. PubMed ID: 2539669
    [No Abstract]   [Full Text] [Related]  

  • 4. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
    Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
    Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells.
    McCaughan GW; Brown MH; Callard RE
    Immunology; 1986 Aug; 58(4):597-602. PubMed ID: 3015782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of alloantigen-activated human lymphocytes cytotoxic for autologous EB virus-transformed lymphoblastoid cell lines.
    Zarling JM
    Transplant Proc; 1981 Dec; 13(4):1893-6. PubMed ID: 6277059
    [No Abstract]   [Full Text] [Related]  

  • 10. Dithiothreitol treatment of crossmatch sera in highly immunized transplant recipients.
    Rudy T; Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):800-2. PubMed ID: 3274876
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity.
    Spits H; Ijssel H; Terhorst C; de Vries JE
    J Immunol; 1982 Jan; 128(1):95-9. PubMed ID: 6274958
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
    Tsukuda K; Berczi I; Klein G
    J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of T cell subpopulations in the control of the proliferative potential of EBV transformed B cells.
    Masucci MG; Klein E
    Behring Inst Mitt; 1983 May; (72):163-8. PubMed ID: 6152688
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-transformed oligoclonal B cell lines producing a cytotoxic human autoantibody.
    Weber BK; al-Muzairai IA; Power DA
    Transplantation; 1991 Mar; 51(3):728-30. PubMed ID: 1848732
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.
    Fior R; Vita N; Raphael M; Minty A; Maillot MC; Crevon MC; Caput D; Biberfeld P; Ferrara P; Galanaud P
    Eur Cytokine Netw; 1994; 5(6):593-600. PubMed ID: 7727691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo generation of cytokine-induced killer cells (CD3+ CD56+) from post-stem cell transplant pediatric patients against autologous-Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Petvises S; Pakakasama S; Wongkajornsilp A; Sirireung S; Panthangkool W; Hongeng S
    Pediatr Transplant; 2007 Aug; 11(5):511-7. PubMed ID: 17631019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.